We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The chair of the Advisory Council on the Misuse of Drugs writes to Karen Bradley about Pregabalin and Gabapentin.
Further advice from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Office about the scheduling of cannabis-derived medicinal products.
The ACMD has recommended that cannabis-derived medicinal products should be placed in Schedule 2 of the Misuse of Drugs Regulations 2001.
Advice from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Office about the scheduling of cannabis-derived medicinal products.
Home Secretary to receive advice on cannabis-related medicinal products.
First published during the 2016 to 2019 May Conservative government
The Advisory Council on the Misuse of Drugs has been asked to consider the appropriate scheduling of cannabis-related products.
We are holding a public evidence gathering day on drug-related harms in homeless populations as part of a commission from government to report on vulnerable people and drug misuse.
The ACMD is holding a public evidence gathering day on drug misuse in prisons and the harms associated with transitions between custody and the community.
The letter is a request for evidence for the ACMD’s “community-custody transitions” working group.
Letter to Victoria Atkins MP from the chair of the Advisory Council on the Misuse of Drugs outlining recommendations for amending the safe custody regulations.
The Home Secretary has appointed a further new member to the Advisory Council for the Misuse of Drugs (ACMD).
Letter to the Home Secretary from the chair of the Advisory Council on the Misuse of Drugs, outlining their work programme for 2017 to 2019.
The Home Secretary has today appointed new members to the Advisory Council for the Misuse of Drugs (ACMD).
The chair of the ACMD responds to the Home Secretary's invitation on 29 November to become a member of the drug strategy board.
Funding cuts are the single biggest threat to drug treatment recovery outcomes, a report published by the ACMD has warned.
The ACMD is holding a public evidence gathering day on Image and Performance Enhancing Drugs on Tuesday 26 September at The Kia Oval, Vauxhall, London.
The Home Office is looking for 11 new members to join the ACMD advisory council.
Further letter from the Advisory Council on the Misuse of Drugs about U-47,700 and designer benzodiazepines.
Letter from the ACMD recommending a temporary class drug order for U-47,700, etizolam and other designer benzodiazepines.
A letter to the Advisory Council on the Misuse of Drugs about U-47,700 and designer benzodiazepines.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).